Sehr P - Search Results

1

Comparison of the immunogenicity and reactogenicity of Cervarix and Gardasil human papillomavirus vaccines in HIV-infected adults: a randomized, double-blind clinical trial.

Toft L, Storgaard M, Müller M, Sehr P, Bonde J, Tolstrup M, Østergaard L, Søgaard OS. Toft L, et al. Among authors: sehr p. J Infect Dis. 2014 Apr 15;209(8):1165-73. doi: 10.1093/infdis/jit657. Epub 2013 Nov 23. J Infect Dis. 2014. PMID: 24273179 Clinical Trial.

2

HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase.

Sehr P, Müller M, Höpfl R, Widschwendter A, Pawlita M. Sehr P, et al. J Virol Methods. 2002 Oct;106(1):61-70. doi: 10.1016/s0166-0934(02)00134-9. J Virol Methods. 2002. PMID: 12367730

3

Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.

Ohlschläger P, Osen W, Dell K, Faath S, Garcea RL, Jochmus I, Müller M, Pawlita M, Schäfer K, Sehr P, Staib C, Sutter G, Gissmann L. Ohlschläger P, et al. Among authors: sehr p. J Virol. 2003 Apr;77(8):4635-45. doi: 10.1128/jvi.77.8.4635-4645.2003. J Virol. 2003. PMID: 12663770 Free PMC article.

4

Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types.

Rizk RZ, Christensen ND, Michael KM, Müller M, Sehr P, Waterboer T, Pawlita M. Rizk RZ, et al. Among authors: sehr p. J Gen Virol. 2008 Jan;89(Pt 1):117-129. doi: 10.1099/vir.0.83145-0. J Gen Virol. 2008. PMID: 18089735

5

The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies.

Rubio I, Seitz H, Canali E, Sehr P, Bolchi A, Tommasino M, Ottonello S, Müller M. Rubio I, et al. Among authors: sehr p. Virology. 2011 Jan 20;409(2):348-59. doi: 10.1016/j.virol.2010.10.017. Epub 2010 Nov 11. Virology. 2011. PMID: 21074234 Free article.

6

High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses.

Sehr P, Rubio I, Seitz H, Putzker K, Ribeiro-Müller L, Pawlita M, Müller M. Sehr P, et al. PLoS One. 2013 Oct 4;8(10):e75677. doi: 10.1371/journal.pone.0075677. eCollection 2013. PLoS One. 2013. PMID: 24124504 Free PMC article.

7

Comparison of the immunogenicity of Cervarix® and Gardasil® human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults.

Toft L, Tolstrup M, Müller M, Sehr P, Bonde J, Storgaard M, Østergaard L, Søgaard OS. Toft L, et al. Among authors: sehr p. Hum Vaccin Immunother. 2014;10(5):1147-54. doi: 10.4161/hv.27925. Epub 2014 Feb 19. Hum Vaccin Immunother. 2014. PMID: 24553190 Free PMC article. Clinical Trial.

8

Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18.

Brown D, Müller M, Sehr P, Pawlita M, Seitz H, Rubio I, Antonello J, Radley D, Roberts C, Saah A. Brown D, et al. Among authors: sehr p. Vaccine. 2014 Oct 7;32(44):5880-7. doi: 10.1016/j.vaccine.2014.08.004. Epub 2014 Aug 19. Vaccine. 2014. PMID: 25148777

9

Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study.

Sankaranarayanan R, Prabhu PR, Pawlita M, Gheit T, Bhatla N, Muwonge R, Nene BM, Esmy PO, Joshi S, Poli UR, Jivarajani P, Verma Y, Zomawia E, Siddiqi M, Shastri SS, Jayant K, Malvi SG, Lucas E, Michel A, Butt J, Vijayamma JM, Sankaran S, Kannan TP, Varghese R, Divate U, Thomas S, Joshi G, Willhauck-Fleckenstein M, Waterboer T, Müller M, Sehr P, Hingmire S, Kriplani A, Mishra G, Pimple S, Jadhav R, Sauvaget C, Tommasino M, Pillai MR; Indian HPV Vaccine Study Group. Sankaranarayanan R, et al. Among authors: sehr p. Lancet Oncol. 2016 Jan;17(1):67-77. doi: 10.1016/S1470-2045(15)00414-3. Epub 2015 Dec 2. Lancet Oncol. 2016. PMID: 26652797 Free PMC article. Clinical Trial.

10

Human Papillomavirus neutralizing and cross-reactive antibodies induced in HIV-positive subjects after vaccination with quadrivalent and bivalent HPV vaccines.

Faust H, Toft L, Sehr P, Müller M, Bonde J, Forslund O, Østergaard L, Tolstrup M, Dillner J. Faust H, et al. Among authors: sehr p. Vaccine. 2016 Mar 18;34(13):1559-1565. doi: 10.1016/j.vaccine.2016.02.019. Epub 2016 Feb 16. Vaccine. 2016. PMID: 26896686 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page